Medtronic plc. (MDT): Valuation
TTM figures as of July 31, 2026
Medtronic plc. trades at 22.2 times trailing earnings and a 5.27% free-cash-flow yield. On P/E that is higher than 10% of its own month-end history back to 2014. The Healthcare median P/E is 22.9.
Earnings yield 4.50%. Shareholder yield 3.77%. ROIC 12.1%. Piotroski F-score 7 of 9. Net cash $6.2B.
149 month-end valuation observations are on file, starting April 2014.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is MDT cheap versus its own history?
Medtronic plc. trades at 22.2 times trailing earnings and a 5.27% free-cash-flow yield. On P/E that is higher than 10% of its own month-end history back to 2014. The Healthcare median P/E is 22.9.
What is MDT's free-cash-flow yield?
Medtronic plc. currently yields 5.27% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.